Zimmer Biomet Commences Commercial Release of Persona® Revision Knee System
Revision System Completes the Persona Portfolio of Comprehensive and Personalized Knee Replacement Solutions
WARSAW, Ind., Sept. 9, 2019 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced FDA 510(k) clearance for the Persona® Revision Knee System for revision knee replacement procedures. The Company expects to launch the system for patients in the United States over the coming weeks. This revision system offers anatomic components designed to match a patient’s anatomy for a personalized fit. Available with a modern, intuitive instrumentation platform, the Persona Revision Knee System enables surgeons to take a personalized approach to addressing simple to complex revision procedures by offering the flexibility to utilize their preferred surgical approach.
The Persona Revision Knee System utilizes Zimmer Biomet’s proprietary technologies that are designed to enhance optimal fit and function:
- Zimmer Biomet’s Trabecular Metal™ Technology, a unique, highly porous biomaterial made from elemental tantalum with structural, functional and physiological properties similar to that of bone, is the only tantalum-based porous material on the market with over 20 years of history making it one of the most clinically documented technologies.1-3
- Vivacit-E® Highly Crosslinked Polyethylene (HXPE), a bearing surface with actively stabilized Vitamin E designed to protect against oxidation and maintain wear resistance and strength throughout the life of the implant.
“Persona Revision completes Zimmer Biomet’s flagship Persona knee system and enhances our ecosystem of customer-centric solutions that address the needs of our customers and improve patient outcomes,” said Ivan Tornos, Zimmer Biomet’s Group President of Global Orthopedics. “The highly-anticipated release of Persona Revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient’s unique requirements.”
Source: orthofeed.com
